Bristol-Myers to invest in Compugen, collaborate in clinical trials
Reuters India -

Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.

Loading...

Related Articles